NO880935L - Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning. - Google Patents
Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.Info
- Publication number
- NO880935L NO880935L NO88880935A NO880935A NO880935L NO 880935 L NO880935 L NO 880935L NO 88880935 A NO88880935 A NO 88880935A NO 880935 A NO880935 A NO 880935A NO 880935 L NO880935 L NO 880935L
- Authority
- NO
- Norway
- Prior art keywords
- hiv
- virus
- discussion
- procedure
- clinical effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13697887A | 1987-12-23 | 1987-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO880935D0 NO880935D0 (no) | 1988-03-02 |
NO880935L true NO880935L (no) | 1989-06-26 |
Family
ID=22475294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO88880935A NO880935L (no) | 1987-12-23 | 1988-03-02 | Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0325018A3 (ru) |
JP (1) | JP2690493B2 (ru) |
KR (1) | KR890010562A (ru) |
CN (1) | CN1043569A (ru) |
AU (2) | AU1256488A (ru) |
CA (1) | CA1337277C (ru) |
DK (1) | DK112988A (ru) |
FI (1) | FI880960A (ru) |
HU (1) | HU205460B (ru) |
IL (1) | IL85577A0 (ru) |
NO (1) | NO880935L (ru) |
OA (1) | OA08815A (ru) |
PH (1) | PH25365A (ru) |
PT (1) | PT86880B (ru) |
RU (1) | RU1836101C (ru) |
SU (1) | SU1687035A3 (ru) |
ZA (1) | ZA881470B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5278042A (en) * | 1989-02-06 | 1994-01-11 | The United States Of America As Represented By The Department Of Health & Human Services | Method for detecting inhibitors of tat protein |
FR2725214A1 (fr) * | 1994-09-30 | 1996-04-05 | Inst Nat Sante Rech Med | Nouveaux composes utilisables pour la preparation d'agents anti-infectieux |
US5985565A (en) * | 1996-10-09 | 1999-11-16 | Temple University-Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
NZ547283A (en) | 1998-03-20 | 2008-06-30 | Commw Scient Ind Res Org | Control of gene expression |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
EP1147204A1 (en) | 1999-01-28 | 2001-10-24 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
US6207366B1 (en) | 1999-04-14 | 2001-03-27 | Temple University- Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
EP1229134A3 (en) | 2001-01-31 | 2004-01-28 | Nucleonics, Inc | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
CN112088903A (zh) * | 2020-09-28 | 2020-12-18 | 武汉愔紫生物科技有限公司 | 一种大分子蛋白在抗菌抗病毒消毒剂中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2505845A1 (fr) * | 1981-05-13 | 1982-11-19 | Choay Sa | Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage |
DE3380200D1 (en) * | 1982-09-16 | 1989-08-24 | William Alvin Carter | Anti-proliferative action of dsnras on tumor cells |
CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
-
1988
- 1988-02-24 PH PH36551A patent/PH25365A/en unknown
- 1988-02-29 IL IL85577A patent/IL85577A0/xx not_active IP Right Cessation
- 1988-02-29 CA CA000560051A patent/CA1337277C/en not_active Expired - Fee Related
- 1988-03-02 JP JP63047657A patent/JP2690493B2/ja not_active Expired - Fee Related
- 1988-03-02 FI FI880960A patent/FI880960A/fi not_active Application Discontinuation
- 1988-03-02 PT PT86880A patent/PT86880B/pt not_active IP Right Cessation
- 1988-03-02 HU HU881015A patent/HU205460B/hu not_active IP Right Cessation
- 1988-03-02 DK DK112988A patent/DK112988A/da not_active Application Discontinuation
- 1988-03-02 ZA ZA881470A patent/ZA881470B/xx unknown
- 1988-03-02 EP EP88301820A patent/EP0325018A3/en not_active Withdrawn
- 1988-03-02 AU AU12564/88A patent/AU1256488A/en not_active Abandoned
- 1988-03-02 NO NO88880935A patent/NO880935L/no unknown
- 1988-03-03 CN CN88101696A patent/CN1043569A/zh active Pending
- 1988-03-03 SU SU884355467A patent/SU1687035A3/ru active
- 1988-03-03 KR KR1019880002189A patent/KR890010562A/ko not_active Application Discontinuation
- 1988-03-03 OA OA59295A patent/OA08815A/xx unknown
- 1988-10-26 RU SU884356721A patent/RU1836101C/ru active
-
1992
- 1992-05-12 AU AU16187/92A patent/AU660973B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JPH01171500A (ja) | 1989-07-06 |
PT86880B (pt) | 1993-01-29 |
KR890010562A (ko) | 1989-08-09 |
CN1043569A (zh) | 1990-07-04 |
ZA881470B (en) | 1988-11-18 |
CA1337277C (en) | 1995-10-10 |
HUT47745A (en) | 1989-03-28 |
DK112988D0 (da) | 1988-03-02 |
PH25365A (en) | 1991-05-13 |
AU660973B2 (en) | 1995-07-13 |
PT86880A (pt) | 1988-04-01 |
EP0325018A2 (en) | 1989-07-26 |
HU205460B (en) | 1992-04-28 |
IL85577A0 (en) | 1988-08-31 |
OA08815A (en) | 1989-03-31 |
JP2690493B2 (ja) | 1997-12-10 |
EP0325018A3 (en) | 1990-01-17 |
AU1618792A (en) | 1992-09-10 |
DK112988A (da) | 1989-06-24 |
AU1256488A (en) | 1989-06-29 |
FI880960A0 (fi) | 1988-03-02 |
FI880960A (fi) | 1989-06-24 |
NO880935D0 (no) | 1988-03-02 |
RU1836101C (ru) | 1993-08-23 |
SU1687035A3 (ru) | 1991-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO885106L (no) | Fremgangsmaate ved fremstilling av cytidin-derivater. | |
NO870579L (no) | Fremgangsmaate for fremstilling av indolizin-derivater. | |
NO165843C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner. | |
NO862651D0 (no) | Fremgangsmaate for fremstilling av isoksazol- og furanderivater. | |
NO873822D0 (no) | Framgangsmaate for tilvirkning av keramiske kompositter. | |
NO159274C (no) | Analogifremgangsmaate for fremstilling av fenyl-alifatisk-isoksazoler for bekjempelse av virus. | |
NO880262D0 (no) | Fremgangsmaate for fremstilling av b avermectiner. | |
NO874467D0 (no) | Fremgangsmaate for fremstilling av 3-pyrrolidinoler. | |
NO880935D0 (no) | Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning. | |
NO883392D0 (no) | Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater. | |
NO873824D0 (no) | Framgangsmaate for tilvirkning av keramiske kompositter. | |
NO861189L (no) | Fremgangsmaate for fremstilling av alfa-l-aspartyl-l-fenylalanin-methylester eller hydroklorid derav. | |
NO863113D0 (no) | Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner. | |
NO873400L (no) | Fremgangsmaate for fremstilling av sulfidfri alkalivaeske. | |
NO871759L (no) | Fremgangsmaate for fremstilling av sucralfatpreparater. | |
NO873727L (no) | Fremgangsmaate for fremstilling av benzoksazoninforbindelser med terapeutisk aktivitet. | |
NO863434D0 (no) | Fremgangsmaate for fremstilling av metylendioksyfenantren- og stilbenderivater. | |
NO874199D0 (no) | Fremgangsmaate for fremstilling av imidazo-pyridinonderivater. | |
NO872690D0 (no) | Fremgangsmaate for fremstilling av mercaptoacylprolin. | |
NO920080D0 (no) | Fremgangsmaate ved fremstilling av proteiner med fviii aktivitet og/eller fviii derivater | |
NO885446D0 (no) | Fremgangsmaate for fremstilling av kinolincarboxylsyrer. | |
NO872199D0 (no) | Analogifremgangsmaate for fremstilling av alkoxyalkyl- og alkylmercaptoalkylsubstituerte benzofuroisokinoliner. | |
NO862126L (no) | Fremgangsmaate ved fremstilling av deutrert akrylsyre eller deutrert metakrylsyre. | |
NO880345L (no) | Fremgangsmaate for fremstilling av alkyl-tert-butyletere. | |
NO874698D0 (no) | Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater. |